Summary:
Infections are a major cause of morbidity and mortality in patients undergoing high-dose therapy and allogeneic bone marrow transplantation (BMT) despite prophylaxis, use of growth factors and newer antimicrobial drugs. We report the clinical profile of infections among 297 patients who underwent 304 allogeneic transplants between 1986 and December 2001. All patients developed febrile neutropenia. There were 415 documented infections among 304 transplants. This included bacterial (34.9%), viral (42.9%), fungal (15.9%) and other infections (6.3%) including tuberculosis. Bacterial pathogens were mainly Gram-negative bacteria (80%) as compared to Gram-positive (20%) bacteria. The common Gram-negative bacteria were nonfermenting Gram-negative bacteria (NFGNB) (24.9%), Pseudomonas (17.9%), Escherichia coli (17.9%) and Klebsiella (9.7%). The major source of positive cultures was blood (53.7%) followed by urine (25.5%) and sputum (8.9%). In all, 133/304 (43.7%) transplants had 178 documented viral infections. The common viral infections were due to cytomegalovirus, herpes group of viruses and transfusion-related hepatitis; and 60/304 (19.7%) transplants had 66 documented fungal infections. Common fungi included Aspergillus species (69.7%), Candida (22.2%) and Zygomycetes (8.1%). Tuberculosis was documented in 2.3% of the transplants. Catheter infections were suspected or documented in 7.8% of the transplants (24/304). The incidence of infections in this series from developing countries is not significantly different from reports from the West.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: international consensus. Clin Infect Dis 2002; 34: 7–14.
Kruger W, Russmann B, Kroger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single center investigation of 409 cases. Bone Marrow Transplant 1999; 23: 589–597.
Tomas JF, Hernandez LM, Penarrubia MJ et al. Early bacterial infections in 103 patients treated with bone marrow transplantation. Sangre (Barc) 1994; 39: 191–196.
Collin BA, Leather HL, Wingard JR et al. Evolution, incidence and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947–953.
Gupta S, Kumar L, Raju GM et al. Autologous bone marrow/stem cell transplantation: initial experience at a North Indian referral center. Natl Med J India 2000; 13: 61–66.
Ghosh K, Shenoy AK, Al-Mahrooqi Z . Bacteriological infections during the first hundred days of allogeneic bone marrow transplantation – experience from Oman. J Assoc Physicians India 2002; 50: 910–912.
Arns da Cunha C, Weisdorf D, Shu XO et al. Early gram positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 1998; 21: 173–180.
Wingard JR . Viral infections in leukemia and bone marrow transplant patients. Leuk Lymphoma 1993; 11 (Suppl. 2): 115–125. (review).
Kawasaki H, Takayama J, Ohira M . Herpes zoster infection after bone marrow transplantation in children. J Pediatr 1996; 128: 353–356.
Ip MS, Yuen KY, Chiu EK et al. Pulmonary infections in bone marrow transplantation: the Hong Kong experience. Respiration 1995; 62: 80–83.
Nomura F, Shimokata K, Sakai S et al. Cytomegalovirus pneumonitis occurring after allogeneic bone marrow transplantation: a study of 106 recipients. Jpn J Med 1990; 29: 595–602.
Machado CM, Dulley FL, Vilas Boas et al. CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy. Bone Marrow Transplant 2000; 26: 413–417.
Einsele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86: 2815–2820.
Ustun C, Koc H, Karayalcin S et al. Hepatitis B virus infection in allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 289–293.
Norol F, Roche B, Saint-Marc Girardin MF et al. Hepatitis C virus infection and allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 407–410.
Ninin E, Milpied N, Moreau P et al. Study of bacterial, viral and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001; 33: 41–47.
Hovi L, Saarinen-Pihkala UM, Vettenranta K et al. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999–1004.
Weinberger M, Sacks T, Sulkes J et al. Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J Hosp Infect 1997; 35: 185–195.
Martino R, Subaru M, Rovira M et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002; 116: 475–482.
Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19: 801–808.
George B, Mathews V, Srivastava V et al. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2001; 27: 973–975.
Budak-Alpdogan T, Tangun Y, Kalayoglu-Besisik S et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000; 6: 370–374.
Mary S, Ip M, Yuen KY et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998; 158: 1173–1177.
Roy V, Weisdorf D . Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19: 467–470.
Tuan IZ, Dennison D, Weisdorf DJ . Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 1992; 10: 267–272.
Elishoov H, Or R, Strauss N et al. Nosocomial colonization, septicemia and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine (Baltimore) 1998; 77: 83–101.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
George, B., Mathews, V., Srivastava, A. et al. Infections among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 33, 311–315 (2004). https://doi.org/10.1038/sj.bmt.1704347
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704347
Keywords
This article is cited by
-
Survey of HCMV in allogenic and autologous stem cell transplantation by real-time PCR in Kermanshah, west of Iran
Infectious Agents and Cancer (2021)
-
Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward
The Indian Journal of Pediatrics (2017)
-
Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT
Bone Marrow Transplantation (2009)
-
Stem cell transplantation in India
Bone Marrow Transplantation (2008)
-
Bone marrow transplant cure for β-thalassaemia major: initial experience from a developing country
Annals of Hematology (2008)